128 related articles for article (PubMed ID: 21081200)
21. Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions.
Millan MJ; Marin P; Bockaert J; Mannoury la Cour C
Trends Pharmacol Sci; 2008 Sep; 29(9):454-64. PubMed ID: 18676031
[TBL] [Abstract][Full Text] [Related]
22. [Transplantation of neurotransmitter receptors and ion channels].
Wang JP; Sun MJ
Sheng Li Ke Xue Jin Zhan; 1987 Apr; 18(2):131-5. PubMed ID: 2443969
[No Abstract] [Full Text] [Related]
23. Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement.
Di Chiara G; Valentini V; Fenu S
Int Rev Neurobiol; 2011; 96():111-39. PubMed ID: 21329786
[No Abstract] [Full Text] [Related]
24. Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics. Focus on dopamine (D1, D3, D4) and 5-HT2a receptors.
Harrison PJ
Br J Psychiatry Suppl; 1999; (38):12-22. PubMed ID: 10884896
[No Abstract] [Full Text] [Related]
25. Neurotransmitters. ATP joins the fast lane.
Benham CD
Nature; 1992 Sep; 359(6391):103-4. PubMed ID: 1355856
[No Abstract] [Full Text] [Related]
26. Integrating the neurobiology of schizophrenia. Preface.
Abi-Dargham A; Guillin O
Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
[No Abstract] [Full Text] [Related]
27. Synaptosomes as a tool in the development of new neuroactive drugs.
Raiteri M
Rev Pure Appl Pharmacol Sci; 1983; 4(1):65-109. PubMed ID: 6142503
[No Abstract] [Full Text] [Related]
28. Neurochemical mechanisms of action of ECS: evidence from in vivo studies.
Newman ME; Gur E; Shapira B; Lerer B
J ECT; 1998 Sep; 14(3):153-71. PubMed ID: 9773355
[TBL] [Abstract][Full Text] [Related]
29. Glial heterogeneity and developing neurotransmitter systems.
Lauder JM; Liu J
Perspect Dev Neurobiol; 1994; 2(3):239-50. PubMed ID: 7850357
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic exploitation of neurotransmitter receptors for the design of novel antidepressant drugs.
Palazidou E; Beer MS; Checkley S; Stahl SM
Drug Des Deliv; 1988 May; 2(4):247-56. PubMed ID: 2908222
[TBL] [Abstract][Full Text] [Related]
31. 5-HT6 receptors: a novel target for cognitive enhancement.
Mitchell ES; Neumaier JF
Pharmacol Ther; 2005 Dec; 108(3):320-33. PubMed ID: 16005519
[TBL] [Abstract][Full Text] [Related]
32. 5-HT3 receptors and central effects of ethanol.
Kostowski W
Pol J Pharmacol; 1996; 48(3):243-54. PubMed ID: 9112659
[TBL] [Abstract][Full Text] [Related]
33. A perspective: psychopharmacological aspects of aggression in animals and man.
Singhal RL; Telner JI
Psychiatr J Univ Ott; 1983 Sep; 8(3):145-53. PubMed ID: 6139834
[No Abstract] [Full Text] [Related]
34. Central neuropharmacology of endorphins.
Rossier J; Bloom F
Adv Biochem Psychopharmacol; 1979; 20():165-85. PubMed ID: 38639
[No Abstract] [Full Text] [Related]
35. 5-HT6 pharmacology inconsistencies.
Borsini F; Bordi F; Riccioni T
Pharmacol Biochem Behav; 2011 Apr; 98(2):169-72. PubMed ID: 21192969
[TBL] [Abstract][Full Text] [Related]
36. [Serotonin receptors in the brain of animals selected for their domesticated type of behavior].
Maslova GB; Avgustinovich DF
Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(4):627-32. PubMed ID: 2816046
[TBL] [Abstract][Full Text] [Related]
37. [The chemistry of cerebral communications].
Changeux JP
Bull Acad Natl Med; 1993 Dec; 177(9):1573-85. PubMed ID: 7912990
[No Abstract] [Full Text] [Related]
38. Graham Johnston: bringing success to neuroscience through medicinal chemistry. Preface.
Beart PM; Balcar VJ
Neurochem Res; 2009 Oct; 34(10):1696-7. PubMed ID: 19484383
[No Abstract] [Full Text] [Related]
39. [Neurotransmitter and brain function].
Haga T
Tanpakushitsu Kakusan Koso; 1995 Apr; 40(6):643-53. PubMed ID: 7754049
[No Abstract] [Full Text] [Related]
40. Cognition: the ultimate brain function.
Robbins TW
Neuropsychopharmacology; 2011 Jan; 36(1):1-2. PubMed ID: 21116247
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
